Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.7K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.7K
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

214
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
214
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

80
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
80
Correlations02:20

Correlations

35.3K
Correlation means that there is a relationship between two or more variables (such as ice cream consumption and crime), but this relationship does not necessarily imply cause and effect. When two variables are correlated, it simply means that as one variable changes, so does the other. We can measure correlation by calculating a statistic known as a correlation coefficient. A correlation coefficient is a number from -1 to +1 that indicates the strength and direction of the relationship between...
35.3K
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

10.3K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
10.3K
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

100
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
100

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same author

Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer.

Frontiers in oncology·2025
Same author

Novel Prostate Biopsy Technique Using Imaging Fusion in a Patient With Absent Rectum.

Urology·2024
Same author

Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer.

JCO oncology practice·2023
Same author

The relationship of depression, alcohol and marijuana with treatment for LUTS/BPH.

The Canadian journal of urology·2022
Same author

A prospective survey study of lower urinary tract dysfunction in childhood cancer survivors after vincristine and/or doxorubicin chemotherapy.

Pediatric blood & cancer·2021

Related Experiment Video

Updated: Nov 18, 2025

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.6K

Marijuana, Alcohol, and ED: Correlations with LUTS/BPH.

Granville L Lloyd1,2, Brett Wiesen3, Mike Atwell4

  • 1Rocky Mountain Regional Veterans Hospital, Aurora, CO, USA. GRANVILLE.LLOYD@CUANSCHUTZ.EDU.

Current Urology Reports
|February 8, 2021
PubMed
Summary

Lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) are linked to depression and erectile dysfunction (ED). Marijuana may offer short-term LUTS/BPH benefits but requires caution.

Keywords:
BPHEDLUTSMarijuanaProstateVoiding

More Related Videos

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

501
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.1K

Related Experiment Videos

Last Updated: Nov 18, 2025

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.6K
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

501
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.1K

Area of Science:

  • Urology
  • Psychiatry
  • Pharmacology

Background:

  • Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) present a significant societal challenge.
  • The underlying pathogenesis of LUTS/BPH remains incompletely understood.
  • Existing research has not fully elucidated the connections between depression, marijuana use, and erectile dysfunction (ED) in relation to LUTS/BPH.

Purpose of the Study:

  • To conduct a literature review examining the associations between depression, marijuana usage, and ED with LUTS/BPH.
  • To synthesize current knowledge on the interplay of these conditions.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of population studies and research on cannabinoid receptors.

Main Results:

  • LUTS/BPH demonstrates independent associations with both depression and ED.
  • The precise causal and mechanistic links between LUTS/BPH, depression, and ED are not yet established.
  • Marijuana's impact on LUTS/BPH is under-researched; current findings suggest potential short-term benefits but warrant long-term caution.
  • Depression (central nervous dysfunction) and ED (potentially endothelial dysfunction) are independently linked to LUTS/BPH.
  • Cannabinoid receptors in urologic organs and population studies suggest marijuana may modulate voiding, though significant knowledge gaps persist.

Conclusions:

  • Depression and ED are independently associated with LUTS/BPH, with unknown causality.
  • Marijuana's role in LUTS/BPH requires further investigation, balancing potential benefits against long-term risks.
  • Further research is crucial to understand the complex interactions and develop effective management strategies for LUTS/BPH.